Stocks and Investing Stocks and Investing
Wed, September 9, 2020
Tue, September 8, 2020

Joel Beatty Initiated (ALNY) at Strong Buy and Held Target at $170 on, Sep 8th, 2020


Published on 2024-10-27 13:04:17 - WOPRAI, Joel Beatty
  Print publication without navigation


Joel Beatty of Citigroup, Initiated "Alnylam Pharmaceuticals, Inc." (ALNY) at Strong Buy and Held Target at $170 on, Sep 8th, 2020.

Joel has made no other calls on ALNY in the last 4 months.



There are 5 other peers that have a rating on ALNY. Out of the 5 peers that are also analyzing ALNY, 4 agree with Joel's Rating of Hold. Following are those relevant analyst calls for the last 4 months


  • Leland Gershell of "Oppenheimer" Downgraded from Buy to Hold and Decreased Target to $156 on, Tuesday, August 11th, 2020
  • Mani Foroohar of "SVB Leerink" Maintained at Hold with Increased Target to $90 on, Friday, August 7th, 2020
  • Esther Rajavelu of "UBS" Maintained at Hold with Increased Target to $122 on, Thursday, May 28th, 2020
  • Luca Issi of "RBC Capital" Initiated at Hold and Held Target at $150 on, Wednesday, May 13th, 2020


This is the rating of the analyst that currently disagrees with Joel


  • David Lebovitz of "Morgan Stanley" Maintained at Buy with Decreased Target to $197 on, Friday, August 7th, 2020
Contributing Sources